Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
End points for cardiovascular drug trials in pediatric patients
Alan R Sinaiko
, Ronald M. Lauer
, Stephen P. Sanders
Pediatric Nephrology
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'End points for cardiovascular drug trials in pediatric patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pediatric Patients
100%
Cardiovascular Disease
100%
Cardiovascular Drugs
100%
Drug Trials
100%
Illness
50%
Clinical Endpoints
50%
Treatment Efficacy
50%
Pediatric Research
50%
Clinical Investigator
50%
Clinical Significance
50%
Low Blood Pressure
50%
Ventricular Function
50%
Blood Lipid Profile
50%
Blood Clot Formation
50%
Medicine and Dentistry
Pediatrics Patient
100%
Cardiovascular Disease
100%
Drug Screening
100%
Cardiovascular Agent
100%
Pediatrics
50%
Hypotension
50%
Clinical Significance
50%
Heart Ventricle Function
50%
Blood Clotting
50%
Blood Clot
50%
Drug Screening
50%
Diseases
50%
Biochemistry, Genetics and Molecular Biology
Blood Lipids
100%
Coagulation System
100%
Blood Pressure
100%
Heart Ventricle Function
100%
Blood Clot
100%
Drug Screening
100%